Neural regulation of bone: from central neural circuits to peripheral innervation of the skeletal stem cell niche

Abstract

The nervous system has emerged as a multi-scale regulator of bone biology, integrating central neural circuits with peripheral innervation to control skeletal homeostasis and repair. While bone remodeling is classically described as being governed by coupling between bone formation and resorption, neural signaling provides an additional hierarchical layer that links organism-level cues to local skeletal stem/progenitor cell niches. This review presents a mechanistic framework for the neuro–bone regulatory network across three hierarchical levels. First, we examine central regulation, in which hypothalamic circuits integrate hormonal and metabolic signals via circumventricular organs to modulate endocrine outputs such as parathyroid hormone (PTH), thereby establishing circadian rhythms and systemic control of bone metabolism. Second, we analyze peripheral neural communication, where sensory inputs triggered by injury or inflammation, along with autonomic efferent signaling, including β-adrenergic pathways, directly influence osteolineage and stromal cells. These signals recalibrate cellular metabolic states, differentiation programs, and regenerative responses, linking pain perception with tissue repair mechanisms. Third, we investigate the bone marrow niche, where distinct subtypes of nerve fibers release a diverse array of neurotransmitters and or neuromodulators that shape the microenvironment of skeletal stem and progenitor cells (SSPCs) as well as downstream osteoprogenitors, thereby regulating proliferation, lineage commitment, and quiescence. Collectively, these findings delineate an integrated model of neural regulation of bone spanning central, peripheral, and local niche levels, providing a foundation for testable hypotheses in neuro-osteobiology.

References

[1] Boyce, B. F. et al. Regulation of bone remodeling and emerging breakthrough drugs for osteoporosis and osteolytic bone metastases. Kidney Int. Suppl. S2–S5 (2003).

[2] Feng X, McDonald JM. Disorders of bone remodeling. Annu. Rev. Pathol., 2011, 6: 121-145

[3] Duda GN, et al. . The decisive early phase of bone regeneration. Nat. Rev. Rheumatol., 2023, 19: 78-95

[4] Spiegel A, Kalinkovich A, Shivtiel S, Kollet O, Lapidot T. Stem cell regulation via dynamic interactions of the nervous and immune systems with the microenvironment. Cell Stem Cell, 2008, 3: 484-492

[5] Tang Y, et al. . TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat. Med., 2009, 15: 757-765

[6] Plotkin LI, Bellido T. Osteocytic signalling pathways as therapeutic targets for bone fragility. Nat. Rev. Endocrinol., 2016, 12: 593-605

[7] Rachner TD, Khosla S, Hofbauer LC. Osteoporosis: now and the future. Lancet, 2011, 377: 1276-1287

[8] Sun W, et al. . Neuro-bone tissue engineering: emerging mechanisms, potential strategies, and current challenges. Bone Res., 2023, 11: 65

[9] Wang T, et al. . Bioprinted constructs that simulate nerve-bone crosstalk to improve microenvironment for bone repair. Bioact. Mater., 2023, 27: 377-393

[10] Wang XD, et al. . The neural system regulates bone homeostasis via mesenchymal stem cells: a translational approach. Theranostics, 2020, 10: 4839-4850

[11] Lerner TN, Ye L, Deisseroth K. Communication in neural circuits: tools, opportunities, and challenges. Cell, 2016, 164: 1136-1150

[12] Zaidi M. Neural surveillance of skeletal homeostasis. Cell Metab., 2005, 1: 219-221

[13] Wang T, Teng B, Yao DR, Gao W, Oka Y. Organ-specific sympathetic innervation defines visceral functions. Nature, 2025, 637: 895-902

[14] Haddad-Tóvolli R, Dragano NRV, Ramalho AFS, Velloso LA. Development and function of the blood-brain barrier in the context of metabolic control. Front. Neurosci., 2017, 11: 224

[15] Zhang L, et al. . Bidirectional control of parathyroid hormone and bone mass by subfornical organ. Neuron, 2023, 111: 1914-1932.e1916

[16] Ducy P, et al. . Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell, 2000, 100: 197-207

[17] Xue P, et al. . PGE2/EP4 skeleton interoception activity reduces vertebral endplate porosity and spinal pain with low-dose celecoxib. Bone Res., 2021, 9: 36

[18] Guo Q, et al. . Unloading-induced skeletal interoception alters hypothalamic signaling to promote bone loss and fat metabolism. Adv. Sci., 2023, 10 e2305042

[19] Chen H, et al. . Prostaglandin E2 mediates sensory nerve regulation of bone homeostasis. Nat. Commun., 2019, 10 181

[20] Gao F, et al. . Brain regulates weight-bearing bone through PGE2 skeletal interoception: implication of ankle osteoarthritis and pain. Bone Res., 2024, 12: 16

[21] Bai L, et al. . Skeletal interoception and prospective application in biomaterials for bone regeneration. Bone Res., 2025, 13: 1

[22] Xiao Y, et al. . Interoceptive regulation of skeletal tissue homeostasis and repair. Bone Res., 2023, 11: 48

[23] Lv X, Gao F, Cao X. Skeletal interoception in bone homeostasis and pain. Cell Metab., 2022, 34: 1914-1931

[24] Morrison SJ, Scadden DT. The bone marrow niche for haematopoietic stem cells. Nature, 2014, 505: 327-334

[25] Kusumbe AP, Ramasamy SK, Adams RH. Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone. Nature, 2014, 507: 323-328

[26] Mizuhashi K, et al. . Resting zone of the growth plate houses a unique class of skeletal stem cells. Nature, 2018, 563: 254-258

[27] Chan CKF, et al. . Identification of the human skeletal stem cell. Cell, 2018, 175: 43-56.e21

[28] Chan CK, et al. . Identification and specification of the mouse skeletal stem cell. Cell, 2015, 160: 285-298

[29] Cong T, et al. . Skeletal stem cells: a basis for orthopaedic pathology and tissue repair. J. Bone Jt. Surg. Am., 2025, 107: 418-426

[30] Xu R, et al. . Targeting skeletal endothelium to ameliorate bone loss. Nat. Med, 2018, 24: 823-833

[31] Feng H, et al. . Skeletal stem cells: origins, definitions, and functions in bone development and disease. Life Med., 2022, 1: 276-293

[32] Yuan G, Lin X, Liu Y, Greenblatt MB, Xu R. Skeletal stem cells in bone development, homeostasis, and disease. Protein Cell, 2024, 15: 559-574

[33] Wu, Z. et al. Axon guidance cue SLIT2 regulates the murine skeletal stem cell niche through sympathetic innervation. J Clin Invest.135, e193014 (2025).

[34] Wu, Z. et al. The p75 neurotrophin receptor controls the skeletal stem cell niche through sensory innervation. Dev. Cell. 61, 259-275.e7 (2026).

[35] Li N, et al. . Schnurri-3 inhibition rescues skeletal fragility and vascular skeletal stem cell niche pathology in the OIM model of osteogenesis imperfecta. Bone Res., 2024, 12: 46

[36] Han Y, You X, Xing W, Zhang Z, Zou W. Paracrine and endocrine actions of bone-the functions of secretory proteins from osteoblasts, osteocytes, and osteoclasts. Bone Res., 2018, 6: 16

[37] Chen Y, et al. . Unraveling the mechanisms of bone diseases: targeting dendritic cells in osteoimmunology for internal homeostasis balance. Bone Res., 2025, 13: 81

[38] Okamoto K, et al. . Osteoimmunology: the conceptual framework unifying the immune and skeletal systems. Physiol. Rev., 2017, 97: 1295-1349

[39] Walsh MC, et al. . Osteoimmunology: interplay between the immune system and bone metabolism. Annu. Rev. Immunol., 2006, 24: 33-63

[40] Walsh MC, Takegahara N, Kim H, Choi Y. Updating osteoimmunology: regulation of bone cells by innate and adaptive immunity. Nat. Rev. Rheumatol., 2018, 14: 146-156

[41] Liang TZ, et al. . Targeting the central and peripheral nervous system to regulate bone homeostasis: mechanisms and potential therapies. Mil. Med. Res., 2025, 12: 13

[42] Ryu, V. et al. An atlas of brain-bone sympathetic neural circuits in mice. Elife13, e95727 (2024).

[43] Dénes A, et al. . Central autonomic control of the bone marrow: multisynaptic tract tracing by recombinant pseudorabies virus. Neuroscience, 2005, 134: 947-963

[44] Katsurada K, Patel KP. The role of afferent renal nerves in regulating sympathetic outflow via central nervous system mechanisms. Hypertens. Res., 2024, 47: 1978-1980

[45] Ye ZY, Li DP, Li L, Pan HL. Protein kinase CK2 increases glutamatergic input in the hypothalamus and sympathetic vasomotor tone in hypertension. J. Neurosci., 2011, 31: 8271-8279

[46] Qiao X, Zhou JJ, Li DP, Pan HL. Src kinases regulate glutamatergic input to hypothalamic presympathetic neurons and sympathetic outflow in hypertension. Hypertension, 2017, 69: 154-162

[47] Li DP, Zhou JJ, Zhang J, Pan HL. CaMKII regulates synaptic NMDA receptor activity of hypothalamic presympathetic neurons and sympathetic outflow in hypertension. J. Neurosci., 2017, 37: 10690-10699

[48] Kulkarni SS, Mischel NA, Mueller PJ. Revisiting differential control of sympathetic outflow by the rostral ventrolateral medulla. Front. Physiol., 2022, 13 1099513

[49] Patel KP, Zheng H. Calcineurin controls hypothalamic NMDA receptor activity and sympathetic outflow. Circ. Res., 2022, 131: 361-363

[50] Elefteriou F, et al. . Serum leptin level is a regulator of bone mass. Proc. Natl. Acad. Sci. USA, 2004, 101: 3258-3263

[51] Takeda S, et al. . Leptin regulates bone formation via the sympathetic nervous system. Cell, 2002, 111: 305-317

[52] Elefteriou F, et al. . Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature, 2005, 434: 514-520

[53] Wu Y, et al. . Central adiponectin administration reveals new regulatory mechanisms of bone metabolism in mice. Am. J. Physiol. Endocrinol. Metab., 2014, 306: E1418-E1430

[54] Oury F, et al. . CREB mediates brain serotonin regulation of bone mass through its expression in ventromedial hypothalamic neurons. Genes Dev., 2010, 24: 2330-2342

[55] Baldock PA, et al. . Hypothalamic Y2 receptors regulate bone formation. J. Clin. Invest., 2002, 109: 915-921

[56] Baldock PA, et al. . Hypothalamic control of bone formation: distinct actions of leptin and y2 receptor pathways. J. Bone Miner. Res., 2005, 20: 1851-1857

[57] Maryanovich, M., Takeishi, S. & Frenette, P. S. Neural regulation of bone and bone marrow. Cold Spring Harb. Perspect. Med.8, a031344 (2018).

[58] Bajayo A, et al. . Skeletal parasympathetic innervation communicates central IL-1 signals regulating bone mass accrual. Proc. Natl. Acad. Sci. USA, 2012, 109: 15455-15460

[59] Tamimi A, et al. . Could vagus nerve stimulation influence bone remodeling?. J. Musculoskelet. Neuronal. Interact., 2021, 21: 255-262

[60] Eimar H, Tamimi I, Murshed M, Tamimi F. Cholinergic regulation of bone. J. Musculoskelet. Neuronal. Interact., 2013, 13: 124-132

[61] Bajayo A, et al. . Central IL-1 receptor signaling regulates bone growth and mass. Proc. Natl. Acad. Sci. USA, 2005, 102: 12956-12961

[62] Shi Y, et al. . Signaling through the M(3) muscarinic receptor favors bone mass accrual by decreasing sympathetic activity. Cell Metab., 2010, 11: 231-238

[63] Clarke IJ. Hypothalamus as an endocrine organ. Compr. Physiol., 2015, 5: 217-253

[64] Rosen CJ. Endocrine disorders and osteoporosis. Curr. Opin. Rheumatol., 1997, 9: 355-361

[65] Giustina A, Romanelli G, Candrina R, Giustina G. Growth hormone deficiency in patients with idiopathic adrenocorticotropin deficiency resolves during glucocorticoid replacement. J. Clin. Endocrinol. Metab., 1989, 68: 120-124

[66] Canalis E, Mazziotti G, Giustina A, Bilezikian JP. Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos. Int., 2007, 18: 1319-1328

[67] Williams-Dautovich J, et al. . The CRH-transgenic Cushingoid Mouse Is a Model of Glucocorticoid-Induced Osteoporosis. JBMR, 2017, 1: 46-57

[68] Mills EG, et al. . The relationship between bone and reproductive hormones beyond estrogens and androgens. Endocr. Rev., 2021, 42: 691-719

[69] Misra M. Effects of hypogonadism on bone metabolism in female adolescents and young adults. Nat. Rev. Endocrinol., 2012, 8: 395-404

[70] Nicks KM, Fowler TW, Gaddy D. Reproductive hormones and bone. Curr. Osteoporos. Rep., 2010, 8: 60-67

[71] Nilsson S, et al. . Mechanisms of estrogen action. Physiol. Rev., 2001, 81: 1535-1565

[72] Yao Y, Cai X, Chen Y, Zhang M, Zheng C. Estrogen deficiency-mediated osteoimmunity in postmenopausal osteoporosis. Med. Res. Rev., 2025, 45: 561-575

[73] Eastell R, et al. . Postmenopausal osteoporosis. Nat. Rev. Dis. Prim., 2016, 2 16069

[74] de Roux N, et al. . Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc. Natl. Acad. Sci. USA, 2003, 100: 10972-10976

[75] Herber CB, et al. . Estrogen signaling in arcuate Kiss1 neurons suppresses a sex-dependent female circuit promoting dense strong bones. Nat. Commun., 2019, 10 163

[76] Babey ME, et al. . A maternal brain hormone that builds bone. Nature, 2024, 632: 357-365

[77] Ortiga-Carvalho TM, Chiamolera MI, Pazos-Moura CC, Wondisford FE. Hypothalamus-Pituitary-Thyroid Axis. Compr. Physiol., 2016, 6: 1387-1428

[78] O’Shea PJ, et al. . Advanced bone formation in mice with a dominant-negative mutation in the thyroid hormone receptor β gene due to activation of Wnt/β-catenin protein signaling. J. Biol. Chem., 2012, 287: 17812-17822

[79] Wang L, Shao YY, Ballock RT. Thyroid hormone interacts with the Wnt/beta-catenin signaling pathway in the terminal differentiation of growth plate chondrocytes. J. Bone Miner. Res., 2007, 22: 1988-1995

[80] Cheng S, Xing W, Pourteymoor S, Mohan S. Effects of Thyroxine (T4), 3,5,3’-triiodo-L-thyronine (T3) and their Metabolites on Osteoblast Differentiation. Calcif. Tissue Int., 2016, 99: 435-442

[81] Wang L, Shao YY, Ballock RT. Thyroid hormone-mediated growth and differentiation of growth plate chondrocytes involves IGF-1 modulation of beta-catenin signaling. J. Bone Min. Res., 2010, 25: 1138-1146

[82] Apostu, D. et al. The influence of thyroid pathology on osteoporosis and fracture risk: a review. Diagnostics10, 149 (2020).

[83] Tamma R, et al. . Oxytocin is an anabolic bone hormone. Proc. Natl. Acad. Sci. USA, 2009, 106: 7149-7154

[84] Tamma R, et al. . Regulation of bone remodeling by vasopressin explains the bone loss in hyponatremia. Proc. Natl. Acad. Sci. USA, 2013, 110: 18644-18649

[85] Sun L, et al. . Functions of vasopressin and oxytocin in bone mass regulation. Proc. Natl. Acad. Sci. USA, 2016, 113: 164-169

[86] Murshed, M. Mechanism of bone mineralization. Cold Spring Harb. Perspect. Med.8, a031229 (2018)

[87] Barthel TK, et al. . 1,25-Dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism. J. Steroid Biochem. Mol. Biol., 2007, 103: 381-388

[88] Inoue Y, et al. . Role of the vitamin D receptor in FGF23 action on phosphate metabolism. Biochem. J., 2005, 390: 325-331

[89] Masuyama R, et al. . Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts. J. Clin. Invest., 2006, 116: 3150-3159

[90] Rhee Y, et al. . Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo. Bone, 2011, 49: 636-643

[91] Kuro OM. The Klotho proteins in health and disease. Nat. Rev. Nephrol., 2019, 15: 27-44

[92] Muñoz-Torres M, García-Martín A. Primary hyperparathyroidism. Med. Clin., 2018, 150: 226-232

[93] Insogna KL. Primary hyperparathyroidism. N. Engl. J. Med., 2018, 379: 1050-1059

[94] Devesa J. The Complex World of Regulation of Pituitary Growth Hormone Secretion: The Role of Ghrelin, Klotho, and Nesfatins in It. Front Endocrinol., 2021, 12 636403

[95] Avendaño MS, Vazquez MJ, Tena-Sempere M. Disentangling puberty: novel neuroendocrine pathways and mechanisms for the control of mammalian puberty. Hum. Reprod. Update, 2017, 23: 737-763

[96] van den Beld AW, et al. . The physiology of endocrine systems with ageing. Lancet Diab Endocrinol., 2018, 6: 647-658

[97] Faraut B, Bayon V, Léger D. Neuroendocrine, immune and oxidative stress in shift workers. Sleep. Med. Rev., 2013, 17: 433-444

[98] Scheiermann C, Kunisaki Y, Frenette PS. Circadian control of the immune system. Nat. Rev. Immunol., 2013, 13: 190-198

[99] Khor EC, et al. . The y6 receptor suppresses bone resorption and stimulates bone formation in mice via a suprachiasmatic nucleus relay. Bone, 2016, 84: 139-147

[100] Buijs FN, et al. . The Circadian system: a regulatory feedback network of periphery and brain. Physiology, 2016, 31: 170-181

[101] Schilperoort M, et al. . Circadian disruption by shifting the light-dark cycle negatively affects bone health in mice. FASEB J., 2020, 34: 1052-1064

[102] Qian Z, et al. . PostnataL conditional deletion of bmal1 in osteoblasts enhances trabecular bone formation via increased BMP2 signals. J. Bone Miner. Res., 2020, 35: 1481-1493

[103] Xu C, et al. . Circadian clock regulates bone resorption in mice. J. Bone Miner. Res., 2016, 31: 1344-1355

[104] McElderry JD, et al. . Tracking circadian rhythms of bone mineral deposition in murine calvarial organ cultures. J. Bone Miner. Res., 2013, 28: 1846-1854

[105] Sato S, et al. . Central control of bone remodeling by neuromedin U. Nat. Med., 2007, 13: 1234-1240

[106] Kandel, E. R., Koester, J. D., Mack, S. H. & Siegelbaum, S. A. in Principles of Neural Science, 6e (McGraw Hill, 2021).

[107] Brazill JM, Beeve AT, Craft CS, Ivanusic JJ, Scheller EL. Nerves in bone: evolving concepts in pain and anabolism. J. Bone Miner. Res., 2019, 34: 1393-1406

[108] Steverink JG, et al. . Sensory innervation of human bone: an immunohistochemical study to further understand bone pain. J. Pain., 2021, 22: 1385-1395

[109] Qin Q, et al. . Neurovascular coupling in bone regeneration. Exp. Mol. Med., 2022, 54: 1844-1849

[110] Xu Z, et al. . Interoceptive regulation of bone homeostasis: The interplay between the nervous and skeletal systems in pathophysiology. Pharm. Res., 2025, 218 107850

[111] Xu J, et al. . The effects of Calcitonin gene-related peptide on bone homeostasis and regeneration. Curr. Osteoporos. Rep., 2020, 18: 621-632

[112] Jiang Y, et al. . αCGRP regulates osteogenic differentiation of bone marrow mesenchymal stem cells through ERK1/2 and p38 MAPK Signaling Pathways. Cell Transpl., 2022, 31: 9636897221107636

[113] Wang B, et al. . αCGRP Affects BMSCs’ Migration and Osteogenesis via the Hippo-YAP Pathway. Cell Transpl., 2019, 28: 1420-1431

[114] Zhang Q, et al. . CGRP-modulated M2 macrophages regulate osteogenesis of MC3T3-E1 via Yap1. Arch. Biochem. Biophys., 2021, 697 108697

[115] Wu Z, et al. . Identification of functional modules and key pathways associated with innervation in Graft Bone-CGRP regulates the differentiation of bone marrow mesenchymal stem cells via p38 MAPK and Wnt6/β-Catenin. Stem Cells Int, 2023, 2023 1154808

[116] Li H, et al. . CGRP regulates the age-related switch between osteoblast and adipocyte differentiation. Front. Cell Dev. Biol., 2021, 9 675503

[117] Zhao X, Wu G, Zhang J, Yu Z, Wang J. Activation of CGRP receptor-mediated signaling promotes tendon-bone healing. Sci. Adv., 2024, 10 eadg7380

[118] Maruyama K, et al. . Nociceptors boost the resolution of fungal osteoinflammation via the TRP Channel-CGRP-Jdp2 Axis. Cell Rep., 2017, 19: 2730-2742

[119] Wang L, et al. . Calcitonin-gene-related peptide stimulates stromal cell osteogenic differentiation and inhibits RANKL induced NF-kappaB activation, osteoclastogenesis and bone resorption. Bone, 2010, 46: 1369-1379

[120] He H, et al. . CGRP may regulate bone metabolism through stimulating osteoblast differentiation and inhibiting osteoclast formation. Mol. Med. Rep., 2016, 13: 3977-3984

[121] Akopian A, et al. . Effects of CGRP on human osteoclast-like cell formation: a possible connection with the bone loss in neurological disorders?. Peptides, 2000, 21: 559-564

[122] Mi J, et al. . Implantable electrical stimulation at dorsal root ganglions accelerates osteoporotic fracture healing via calcitonin gene-related peptide. Adv. Sci., 2022, 9 e2103005

[123] Appelt J, et al. . The neuropeptide calcitonin gene-related peptide alpha is essential for bone healing. EBioMedicine, 2020, 59 102970

[124] Wang, Q. et al. Research progress in calcitonin gene-related peptide and bone repair. Biomolecules13, 838 (2023).

[125] Utagawa K, et al. . Three-dimensional visualization of neural networks inside bone by Osteo-DISCO protocol and alteration of bone remodeling by surgical nerve ablation. Sci. Rep., 2023, 13 4674

[126] Niedermair T, Schirner S, Seebröker R, Straub RH, Grässel S. Substance P modulates bone remodeling properties of murine osteoblasts and osteoclasts. Sci. Rep., 2018, 8 9199

[127] Wang L, et al. . Mice lacking substance P have normal bone modeling but diminished bone formation, increased resorption, and accelerated osteopenia with aging. Bone, 2021, 144 115806

[128] Mei G, et al. . Substance P activates the Wnt signal transduction pathway and enhances the differentiation of mouse preosteoblastic MC3T3-E1 cells. Int J. Mol. Sci., 2014, 15: 6224-6240

[129] Wang L, et al. . Substance P stimulates bone marrow stromal cell osteogenic activity, osteoclast differentiation, and resorption activity in vitro. Bone, 2009, 45: 309-320

[130] Sohn SJ. Substance P upregulates osteoclastogenesis by activating nuclear factor kappa B in osteoclast precursors. Acta Otolaryngol., 2005, 125: 130-133

[131] Grässel SG. The role of peripheral nerve fibers and their neurotransmitters in cartilage and bone physiology and pathophysiology. Arthritis Res. Ther., 2014, 16: 485

[132] Piao J, Park JS, Hwang DY, Son Y, Hong HS. Substance P blocks ovariectomy-induced bone loss by modulating inflammation and potentiating stem cell function. Aging, 2020, 12: 20753-20777

[133] Kingery WS, et al. . A substance P receptor (NK1) antagonist enhances the widespread osteoporotic effects of sciatic nerve section. Bone, 2003, 33: 927-936

[134] Sipprell, S. E., Krueger, Q. A., Mills, E. L., Marriott, I. & Johnson, M. B. Substance P augments chemokine production by Staphylococcus aureus infected murine osteoclasts. Inflammation48, 3506–3518 (2025).

[135] Johnson MB, Suptela SR, Sipprell SE, Marriott I. Substance P exacerbates the inflammatory and pro-osteoclastogenic responses of murine osteoclasts and osteoblasts to Staphylococcus aureus. Inflammation, 2023, 46: 256-269

[136] Han X, et al. . Bioactive semaphorin 3A promotes sequential formation of sensory nerve and type H vessels during in situ osteogenesis. Front Bioeng. Biotechnol., 2023, 11 1138601

[137] Fukuda T, et al. . Sema3A regulates bone-mass accrual through sensory innervations. Nature, 2013, 497: 490-493

[138] Silva DI, Santos BPD, Leng J, Oliveira H, Amédée J. Dorsal root ganglion neurons regulate the transcriptional and translational programs of osteoblast differentiation in a microfluidic platform. Cell Death Dis., 2017, 8 3209

[139] Zhang Y, et al. . Semaphorin 3A on osteoporosis: an overreview of the literature. Calcif. Tissue Int., 2025, 116: 43

[140] Hayashi M, et al. . Osteoprotection by semaphorin 3A. Nature, 2012, 485: 69-74

[141] Shi J, et al. . Peripheral nerve-derived Sema3A promotes osteogenic differentiation of mesenchymal stem cells through the Wnt/β-catenin/Nrp1 positive feedback loop. J. Cell Mol. Med., 2024, 28 e18201

[142] Hayashi M, et al. . Autoregulation of osteocyte Sema3A orchestrates estrogen action and counteracts bone aging. Cell Metab., 2019, 29: 627-637.e625

[143] Worzfeld T, Offermanns S. Semaphorins and plexins as therapeutic targets. Nat. Rev. Drug Discov., 2014, 13: 603-621

[144] Huang B, et al. . Sema3a inhibits the differentiation of Raw264.7 cells to osteoclasts under 2Gy radiation by reducing inflammation. PLoS One, 2018, 13: e0200000

[145] Zhang N, Hua Y, Li Y, Pan J. Sema3A accelerates bone formation during distraction osteogenesis in mice. Connect Tissue Res., 2022, 63: 382-392

[146] Kobayashi Y, et al. . Prostaglandin E2 receptors EP2 and EP4 are down-regulated during differentiation of mouse osteoclasts from their precursors. J. Biol. Chem., 2005, 280: 24035-24042

[147] Yoshida K, et al. . Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation. Proc. Natl. Acad. Sci. USA, 2002, 99: 4580-4585

[148] Li M, et al. . Osteopenia and impaired fracture healing in aged EP4 receptor knockout mice. Bone, 2005, 37: 46-54

[149] Wang F, et al. . Nerve growth factors promotes osteogenic differentiation through TGF- β and BMP-9 signaling pathways in bone mesenchymal stem cells. J. Biomater. Tissue Eng., 2020, 10: 46-52

[150] Zheng MG, et al. . TrkA regulates the regenerative capacity of bone marrow stromal stem cells in nerve grafts. Neural Regen. Res., 2019, 14: 1765-1771

[151] Liao J, et al. . TGF-β/BMP signaling in skeletal biology: molecular mechanisms, regulatory networks, and therapeutic implications in development, regeneration, and disease. Bone Res., 2026, 14: 6

[152] Li Z, et al. . Fracture repair requires TrkA signaling by skeletal sensory nerves. J. Clin. Invest., 2019, 129: 5137-5150

[153] Tomlinson RE, et al. . NGF-TrkA signaling by sensory nerves coordinates the vascularization and ossification of developing endochondral bone. Cell Rep., 2016, 16: 2723-2735

[154] Tomlinson RE, et al. . NGF-TrkA signaling in sensory nerves is required for skeletal adaptation to mechanical loads in mice. Proc. Natl. Acad. Sci. USA, 2017, 114: E3632-e3641

[155] Rajpar I, Kumar G, Fortina P, Tomlinson RE. Toll-like receptor 4 signaling in osteoblasts is required for load-induced bone formation in mice. iScience, 2023, 26 106304

[156] Lee S, et al. . NGF-TrkA signaling dictates neural ingrowth and aberrant osteochondral differentiation after soft tissue trauma. Nat. Commun., 2021, 12 4939

[157] Rivera KO, et al. . Local injections of β-NGF accelerates endochondral fracture repair by promoting cartilage to bone conversion. Sci. Rep., 2020, 10 22241

[158] Fioravanti G, Hua PQ, Tomlinson RE. The TrkA agonist gambogic amide augments skeletal adaptation to mechanical loading. Bone, 2021, 147 115908

[159] Jiang Y, et al. . Neuronal TRPV1-CGRP axis regulates bone defect repair through Hippo signaling pathway. Cell Signal, 2023, 109 110779

[160] He LH, et al. . TRPV1 deletion impaired fracture healing and inhibited osteoclast and osteoblast differentiation. Sci. Rep., 2017, 7 42385

[161] Rossi F, et al. . The genetic ablation or pharmacological inhibition of TRPV1 signalling is beneficial for the restoration of quiescent osteoclast activity in ovariectomized mice. Br. J. Pharm., 2014, 171: 2621-2630

[162] Yoneda T, Hiasa M, Nagata Y, Okui T, White FA. Acidic microenvironment and bone pain in cancer-colonized bone. Bonekey Rep., 2015, 4: 690

[163] Morgan M, Nencini S, Thai J, Ivanusic JJ. TRPV1 activation alters the function of Aδ and C fiber sensory neurons that innervate bone. Bone, 2019, 123: 168-175

[164] Wang J, Lu HX, Wang J. Cannabinoid receptors in osteoporosis and osteoporotic pain: a narrative update of review. J. Pharm. Pharm., 2019, 71: 1469-1474

[165] Yoshino K, et al. . Increase of TRPV1-immunoreactivity in dorsal root ganglia neurons innervating the femur in a rat model of osteoporosis. Yonsei Med J., 2014, 55: 1600-1605

[166] Edens BM, Stundl J, Urrutia HA, Bronner ME. Neural crest origin of sympathetic neurons at the dawn of vertebrates. Nature, 2024, 629: 121-126

[167] Sohn R, et al. . Adrenergic signalling in osteoarthritis. Cell Signal, 2021, 82 109948

[168] Lorenz J, et al. . Norepinephrine modulates osteoarthritic chondrocyte metabolism and inflammatory responses. Osteoarthr. Cartil., 2016, 24: 325-334

[169] Fujita S, et al. . Quantitative analysis of sympathetic and nociceptive innervation across bone marrow regions in mice. Exp. Hematol., 2022, 112-113: 44-59.e46

[170] Katayama Y, et al. . Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell, 2006, 124: 407-421

[171] Togari A, Arai M, Kondo A. The role of the sympathetic nervous system in controlling bone metabolism. Expert Opin. Ther. Targets, 2005, 9: 931-940

[172] Uemura T, et al. . Epinephrine accelerates osteoblastic differentiation by enhancing bone morphogenetic protein signaling through a cAMP/protein kinase A signaling pathway. Bone, 2010, 47: 756-765

[173] Kajimura D, et al. . Genetic determination of the cellular basis of the sympathetic regulation of bone mass accrual. J. Exp. Med., 2011, 208: 841-851

[174] Fu L, Patel MS, Bradley A, Wagner EF, Karsenty G. The molecular clock mediates leptin-regulated bone formation. Cell, 2005, 122: 803-815

[175] Farr JN, et al. . Relationship of sympathetic activity to bone microstructure, turnover, and plasma osteopontin levels in women. J. Clin. Endocrinol. Metab., 2012, 97: 4219-4227

[176] Gadomski S, et al. . A cholinergic neuroskeletal interface promotes bone formation during postnatal growth and exercise. Cell Stem Cell, 2022, 29: 528-544.e529

[177] Chen Y, et al. . Sympathetic cholinergic nerve fibres promote BMSC differentiation into osteoblasts via NRTN secretion: a potential treatment for osteoporosis. J. Orthop. Surg. Res., 2025, 20: 571

[178] Zoccali C, et al. . The autonomic nervous system and bone health in chronic kidney disease. Eur. J. Clin. Invest., 2025, 55 e70007

[179] Huang HH, Brennan TC, Muir MM, Mason RS. Functional alpha1- and beta2-adrenergic receptors in human osteoblasts. J. Cell Physiol., 2009, 220: 267-275

[180] Kodama D, Togari A. Noradrenaline stimulates cell proliferation by suppressing potassium channels via G(i/o) -protein-coupled α(1B) -adrenoceptors in human osteoblasts. Br. J. Pharm., 2013, 168: 1230-1239

[181] Elefteriou F, Campbell P, Ma Y. Control of bone remodeling by the peripheral sympathetic nervous system. Calcif. Tissue Int., 2014, 94: 140-151

[182] Han J, et al. . DNA synthesis of rat bone marrow mesenchymal stem cells through alpha1-adrenergic receptors. Arch. Biochem Biophys., 2009, 490: 96-102

[183] Togari A. Adrenergic regulation of bone metabolism: possible involvement of sympathetic innervation of osteoblastic and osteoclastic cells. Microsc. Res. Tech., 2002, 58: 77-84

[184] Tanaka K, et al. . α1B -Adrenoceptor signalling regulates bone formation through the up-regulation of CCAAT/enhancer-binding protein δ expression in osteoblasts. Br. J. Pharm., 2016, 173: 1058-1069

[185] Cuscito C, et al. . Adrenergic stimulation decreases osteoblast oxytocin synthesis. Ann. N. Y Acad. Sci., 2011, 1237: 53-57

[186] Fonseca TL, et al. . Double disruption of α2A- and α2C-adrenoceptors results in sympathetic hyperactivity and high-bone-mass phenotype. J. Bone Miner. Res., 2011, 26: 591-603

[187] Elefteriou F. Regulation of bone remodeling by the central and peripheral nervous system. Arch. Biochem. Biophys., 2008, 473: 231-236

[188] Khosla S, et al. . Sympathetic β1-adrenergic signaling contributes to regulation of human bone metabolism. J. Clin. Invest., 2018, 128: 4832-4842

[189] Guan Z, et al. . Sympathetic innervation induces exosomal miR-125 transfer from osteoarthritic chondrocytes, disrupting subchondral bone homeostasis and aggravating cartilage damage in aging mice. J. Adv. Res., 2025, 69: 245-260

[190] Hu CH, et al. . Sympathetic neurostress drives osteoblastic exosomal MiR-21 transfer to disrupt bone homeostasis and promote osteopenia. Small Methods, 2022, 6 e2100763

[191] Jiao K, et al. . β2-Adrenergic signal transduction plays a detrimental role in subchondral bone loss of temporomandibular joint in osteoarthritis. Sci. Rep., 2015, 5 12593

[192] Kim B-J, Lee SH, Koh J-M. Effects of sympathetic activity on human skeletal homeostasis: clinical evidence from Pheochromocytoma. Clin. Rev. Bone Miner. Metab., 2019, 17: 40-47

[193] Nagao M, et al. . Sympathetic control of bone mass regulated by osteopontin. Proc. Natl. Acad. Sci. USA, 2011, 108: 17767-17772

[194] Liang H, et al. . Selective β2-adrenoreceptor signaling regulates osteoclastogenesis via modulating RANKL production and neuropeptides expression in osteocytic MLO-Y4 cells. J. Cell Biochem., 2019, 120: 7238-7247

[195] Ma Y, et al. . β2-Adrenergic receptor signaling in osteoblasts contributes to the catabolic effect of glucocorticoids on bone. Endocrinology, 2011, 152: 1412-1422

[196] Shao W, et al. . Inhibition of sympathetic tone via hypothalamic descending pathway propagates glucocorticoid-induced endothelial impairment and osteonecrosis of the femoral head. Bone Res., 2024, 12: 64

[197] Xu HK, et al. . Region-specific sympatho-adrenergic regulation of specialized vasculature in bone homeostasis and regeneration. iScience, 2023, 26 107455

[198] Pierroz DD, et al. . Deletion of β-adrenergic receptor 1, 2, or both leads to different bone phenotypes and response to mechanical stimulation. J. Bone Miner. Res., 2012, 27: 1252-1262

[199] Zhu Y, Ma Y, Elefteriou F. Cortical bone is an extraneuronal site of norepinephrine uptake in adult mice. Bone Rep., 2018, 9: 188-198

[200] Ma Y, et al. . Extracellular norepinephrine clearance by the norepinephrine transporter is required for skeletal homeostasis. J. Biol. Chem., 2013, 288: 30105-30113

[201] Donat A, et al. . The selective norepinephrine reuptake inhibitor reboxetine promotes late-stage fracture healing in mice. iScience, 2023, 26 107761

[202] Ofek O, et al. . Peripheral cannabinoid receptor, CB2, regulates bone mass. Proc. Natl. Acad. Sci. USA, 2006, 103: 696-701

[203] Clouse G, Penman S, Hadjiargyrou M, Komatsu DE, Thanos PK. Examining the role of cannabinoids on osteoporosis: a review. Arch. Osteoporos., 2022, 17 146

[204] Idris AI, et al. . Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors. Nat. Med., 2005, 11: 774-779

[205] Deis S, et al. . Age-related regulation of bone formation by the sympathetic cannabinoid CB1 receptor. Bone, 2018, 108: 34-42

[206] Tam J, et al. . Involvement of neuronal cannabinoid receptor CB1 in regulation of bone mass and bone remodeling. Mol. Pharm., 2006, 70: 786-792

[207] Tam J, et al. . The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling. FASEB J., 2008, 22: 285-294

[208] Xin Y, Tang A, Pan S, Zhang J. Components of the Endocannabinoid system and effects of Cannabinoids against bone diseases: a mini-review. Front. Pharm., 2021, 12 793750

[209] Bab I, Zimmer A. Cannabinoid receptors and the regulation of bone mass. Br. J. Pharm., 2008, 153: 182-188

[210] Zimmer A. A collaboration investigating endocannabinoid signalling in brain and bone. J. Basic Clin. Physiol. Pharm., 2016, 27: 229-235

[211] Bab IA. Regulation of skeletal remodeling by the endocannabinoid system. Ann. N. Y Acad. Sci., 2007, 1116: 414-422

[212] Raphael-Mizrahi B, Gabet Y. The Cannabinoids effect on bone formation and bone healing. Curr. Osteoporos. Rep., 2020, 18: 433-438

[213] Zhu Y, et al. . Sympathetic neuropeptide Y protects from obesity by sustaining thermogenic fat. Nature, 2024, 634: 243-250

[214] Wang FS, et al. . Neuropeptide Y mediates glucocorticoid-induced osteoporosis and marrow adiposity in mice. Osteoporos. Int., 2016, 27: 2777-2789

[215] Zhang Y, et al. . Neuronal induction of bone-fat imbalance through osteocyte Neuropeptide Y. Adv. Sci., 2021, 8 e2100808

[216] Chen QC, Zhang Y. The role of NPY in the regulation of bone metabolism. Front Endocrinol. (Lausanne), 2022, 13 833485

[217] Horsnell H, Baldock PA. Osteoblastic actions of the neuropeptide Y system to regulate bone and energy homeostasis. Curr. Osteoporos. Rep., 2016, 14: 26-31

[218] Lee NJ, Herzog H. NPY regulation of bone remodelling. Neuropeptides, 2009, 43: 457-463

[219] Chen Z, et al. . Neuropeptide Y-mediated gut microbiota alterations aggravate postmenopausal osteoporosis. Adv. Sci., 2023, 10 e2303015

[220] Lee NJ, et al. . RANK deletion in neuropeptide Y neurones attenuates oestrogen deficiency-related bone loss. J. Neuroendocrinol., 2019, 31 e12687

[221] Lundberg P, et al. . Greater bone formation of Y2 knockout mice is associated with increased osteoprogenitor numbers and altered Y1 receptor expression. J. Biol. Chem., 2007, 282: 19082-19091

[222] Baldock PA, et al. . Neuropeptide y attenuates stress-induced bone loss through suppression of noradrenaline circuits. J. Bone Miner. Res., 2014, 29: 2238-2249

[223] Hohmann EL, Elde RP, Rysavy JA, Einzig S, Gebhard RL. Innervation of periosteum and bone by sympathetic vasoactive intestinal peptide-containing nerve fibers. Science, 1986, 232: 868-871

[224] Shi L, et al. . Vasoactive intestinal peptide promotes fracture healing in sympathectomized mice. Calcif. Tissue Int., 2021, 109: 55-65

[225] Castro-Vázquez D, et al. . Vasoactive intestinal peptide exerts an osteoinductive effect in human mesenchymal stem cells. Biofactors, 2024, 50: 1148-1160

[226] Castro-Vazquez, D. et al. The neuropeptide VIP limits human osteoclastogenesis: clinical associations with bone metabolism markers in patients with early arthritis. Biomedicines9, 1880 (2021).

[227] Espinosa-Medina I, et al. . Neurodevelopment. Parasympathetic ganglia derive from Schwann cell precursors. Science, 2014, 345: 87-90

[228] Le Douarin, N. & Kalcheim, C. The Neural Crest. 2 edn, (Cambridge University Press, 1999).

[229] Elefteriou F. Impact of the autonomic nervous system on the skeleton. Physiol. Rev., 2018, 98: 1083-1112

[230] Sato T, et al. . Functional role of acetylcholine and the expression of cholinergic receptors and components in osteoblasts. FEBS Lett., 2010, 584: 817-824

[231] En-Nosse M, et al. . Expression of non-neuronal cholinergic system in osteoblast-like cells and its involvement in osteogenesis. Cell Tissue Res., 2009, 338: 203-215

[232] Dyachuk V, et al. . Neurodevelopment. Parasympathetic neurons originate from nerve-associated peripheral glial progenitors. Science, 2014, 345: 82-87

[233] Luo Y, et al. . Divalent metal ions enhance bone regeneration through modulation of nervous systems and metabolic pathways. Bioact. Mater., 2025, 47: 432-447

[234] Eimar H, et al. . Donepezil regulates energy metabolism and favors bone mass accrual. Bone, 2016, 84: 131-138

[235] Ma Y, Elefteriou F. Brain-derived Acetylcholine maintains peak bone mass in adult female mice. J. Bone Miner. Res., 2020, 35: 1562-1571

[236] Qin W, Bauman WA, Cardozo CP. Evolving concepts in neurogenic osteoporosis. Curr. Osteoporos. Rep., 2010, 8: 212-218

[237] Mito K, et al. . The nicotinic acetylcholine receptor α7 subunit is an essential negative regulator of bone mass. Sci. Rep., 2017, 7 45597

[238] Xiao H, et al. . Nicotine exposure during pregnancy programs osteopenia in male offspring rats via α4β2-nAChR-p300-ACE pathway. FASEB J., 2019, 33: 12972-12982

[239] Mandl P, et al. . Nicotinic acetylcholine receptors modulate osteoclastogenesis. Arthritis Res. Ther., 2016, 18: 63

[240] Lips KS, et al. . Small changes in bone structure of female α7 nicotinic acetylcholine receptor knockout mice. BMC Musculoskelet. Disord., 2015, 16 5

[241] Tanaka H, et al. . Nicotine affects bone resorption and suppresses the expression of cathepsin K, MMP-9 and vacuolar-type H⁺-ATPase d2 and actin organization in osteoclasts. PLoS One, 2013, 8: e59402

[242] Guo J, Wang L, Xu H, Che X. Expression of non-neuronal cholinergic system in maxilla of rat in vivo. Biol. Res., 2014, 47 72

[243] Guo H, Che X, Xiang R. Cyclic stretch promotes osteogenesis of osteoblasts via ACh/α7nAChR pathway. J. Biomech., 2025, 183 112616

[244] Baumann L, et al. . Deletion of nicotinic acetylcholine receptor alpha9 in mice resulted in altered bone structure. Bone, 2019, 120: 285-296

[245] Kliemann K, et al. . Quantitative analyses of bone composition in acetylcholine receptor M3R and alpha7 knockout mice. Life Sci., 2012, 91: 997-1002

[246] Zablotni A, et al. . Regulation of acetylcholine receptors during differentiation of bone mesenchymal stem cells harvested from human reaming debris. Int Immunopharmacol., 2015, 29: 119-126

[247] Thangaraj G, Manakov V, Cucu A, Fournier C, Layer PG. Inflammatory effects of TNFα are counteracted by X-ray irradiation and AChE inhibition in mouse micromass cultures. Chem. Biol. Interact., 2016, 259: 313-318

[248] Inkson CA, Brabbs AC, Grewal TS, Skerry TM, Genever PG. Characterization of acetylcholinesterase expression and secretion during osteoblast differentiation. Bone, 2004, 35: 819-827

[249] Sato T, et al. . Donepezil prevents RANK-induced bone loss via inhibition of osteoclast differentiation by downregulating acetylcholinesterase. Heliyon, 2015, 1 e00013

[250] Kauschke V, et al. . Bone status of acetylcholinesterase-knockout mice. Int. Immunopharmacol., 2015, 29: 222-230

[251] Haupt M, et al. . Bone status of adult female butyrylcholinesterase gene-deficient mice. Int. Immunopharmacol., 2015, 29: 208-214

[252] Ambrosi TH, et al. . Aged skeletal stem cells generate an inflammatory degenerative niche. Nature, 2021, 597: 256-262

[253] Yuan G, Li Z, Lin X, Li N, Xu R. New perspective of skeletal stem cells. Biomater. Transl., 2022, 3: 280-294

[254] Debnath S, et al. . Discovery of a periosteal stem cell mediating intramembranous bone formation. Nature, 2018, 562: 133-139

[255] Wagers AJ. The stem cell niche in regenerative medicine. Cell Stem Cell, 2012, 10: 362-369

[256] Picoli CC, et al. . Sensory nerves in the spotlight of the stem cell niche. Stem Cells Transl. Med., 2021, 10: 346-356

[257] Pei F, et al. . Sensory nerve niche regulates mesenchymal stem cell homeostasis via FGF/mTOR/autophagy axis. Nat. Commun., 2023, 14 344

[258] Lu R, et al. . Neurons generated from carcinoma stem cells support cancer progression. Signal Transduct. Target Ther., 2017, 2 16036

[259] Ye, Z., Xu, Y., Zhang, M. & Cai, C. Sympathetic nerve signals: orchestrators of mammary development and stem cell vitality. J. Mol. Cell Biol.16, mjae020 (2024).

[260] Hsu YC, Li L, Fuchs E. Emerging interactions between skin stem cells and their niches. Nat. Med., 2014, 20: 847-856

[261] Maryanovich M, et al. . Adrenergic nerve degeneration in bone marrow drives aging of the hematopoietic stem cell niche. Nat. Med., 2018, 24: 782-791

[262] Wei Q, Frenette PS. Niches for hematopoietic stem cells and their progeny. Immunity, 2018, 48: 632-648

[263] Cheng W, Huang J, Li N, Xu R. Skeletal stem-cell therapy: challenge meets opportunity. Lancet, 2024, 403: 243

[264] Yasui M, et al. . Nerve growth factor and associated nerve sprouting contribute to local mechanical hyperalgesia in a rat model of bone injury. Eur. J. Pain., 2012, 16: 953-965

[265] Chartier SR, et al. . Exuberant sprouting of sensory and sympathetic nerve fibers in nonhealed bone fractures and the generation and maintenance of chronic skeletal pain. Pain, 2014, 155: 2323-2336

[266] Xu M, et al. . Mapping somatosensory afferent circuitry to bone identifies neurotrophic signals required for fracture healing. Science, 2026, 391 eadr9608

[267] Driscoll C, et al. . Nociceptive sensitizers are regulated in damaged joint tissues, including articular cartilage, when osteoarthritic mice display pain behavior. Arthritis Rheumatol., 2016, 68: 857-867

[268] Zhu S, et al. . Subchondral bone osteoclasts induce sensory innervation and osteoarthritis pain. J. Clin. Invest., 2019, 129: 1076-1093

[269] Rajpar I, Tomlinson RE. Function of peripheral nerves in the development and healing of tendon and bone. Semin Cell Dev. Biol., 2022, 123: 48-56

[270] Shu Y, et al. . Inhibition of inflammatory osteoclasts accelerates callus remodeling in osteoporotic fractures by enhancing CGRP⁺TrkA⁺ signaling. Cell Death Differ., 2024, 31: 1695-1706

[271] Hart EC, et al. . Age-related differences in the sympathetic-hemodynamic balance in men. Hypertension, 2009, 54: 127-133

[272] de La Cruz, L., Bui, D., Moreno, C. M. & Vivas, O. Sympathetic motor neuron dysfunction is a missing link in age-associated sympathetic overactivity. Elife12, RP91663 (2024).

[273] Chartier SR, Mitchell SAT, Majuta LA, Mantyh PW. The changing sensory and sympathetic innervation of the young, adult and aging mouse femur. Neuroscience, 2018, 387: 178-190

[274] Yadav VK, et al. . A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure. Cell, 2009, 138: 976-989

[275] Guérardel A, Tankó LB, Boutin P, Christiansen C, Froguel P. Obesity susceptibility CART gene polymorphism contributes to bone remodeling in postmenopausal women. Osteoporos. Int., 2006, 17: 156-157

[276] Zhang F, et al. . Secretin-dependent signals in the ventromedial hypothalamus regulate energy metabolism and bone homeostasis in mice. Nat. Commun., 2024, 15 1030

[277] Luo, N. et al. A neuronal action of sirtuin 1 suppresses bone mass in young and aging mice. J. Clin. Invest.132, e152868 (2022).

[278] Kajimura D, Paone R, Mann JJ, Karsenty G. Foxo1 regulates Dbh expression and the activity of the sympathetic nervous system in vivo. Mol. Metab., 2014, 3: 770-777

[279] Sun L, et al. . FSH directly regulates bone mass. Cell, 2006, 125: 247-260

[280] Chen FP, Hu CH, Wang KC. Estrogen modulates osteogenic activity and estrogen receptor mRNA in mesenchymal stem cells of women. Climacteric, 2013, 16: 154-160

[281] Gavali S, et al. . Estrogen enhances human osteoblast survival and function via promotion of autophagy. Biochim. Biophys. Acta Mol. Cell Res., 2019, 1866: 1498-1507

[282] Guo L, et al. . Estrogen inhibits osteoclasts formation and bone resorption via microRNA-27a targeting PPARγ and APC. J. Cell Physiol., 2018, 234: 581-594

[283] Snyder PJ, et al. . Testosterone treatment and fractures in men with Hypogonadism. N. Engl. J. Med., 2024, 390: 203-211

[284] Baliram R, et al. . Thyroid-stimulating hormone induces a Wnt-dependent, feed-forward loop for osteoblastogenesis in embryonic stem cell cultures. Proc. Natl. Acad. Sci. USA, 2011, 108: 16277-16282

[285] Govindan, R. et al. Thyroid-stimulating hormone favors Runx2-Mediated Matrix Mineralization in HOS and SaOS2 cells: an in vitro and in silico approach. Molecules27, 613 (2022).

[286] Abe E, et al. . TSH is a negative regulator of skeletal remodeling. Cell, 2003, 115: 151-162

[287] Lademann F, et al. . Disruption of BMP Signaling Prevents Hyperthyroidism-Induced Bone Loss in Male Mice. J. Bone Miner. Res., 2020, 35: 2058-2069

[288] Kanatani M, et al. . Thyroid hormone stimulates osteoclast differentiation by a mechanism independent of RANKL-RANK interaction. J. Cell Physiol., 2004, 201: 17-25

[289] St-Jacques B, Hammerschmidt M, McMahon AP. Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev., 1999, 13: 2072-2086

[290] Chung UI, Schipani E, McMahon AP, Kronenberg HM. Indian hedgehog couples chondrogenesis to osteogenesis in endochondral bone development. J. Clin. Invest., 2001, 107: 295-304

[291] Lu, X. et al. Insight into the roles of melatonin in bone tissue and bone‑related diseases (Review). Int. J. Mol. Med.47, 82 (2021).

Funding

National Science Foundation of China | Major Research Plan(92468203)

Natural Science Foundation of Fujian Province (Fujian Provincial Natural Science Foundation)(2022J06003)

RIGHTS & PERMISSIONS

The Author(s)